Expert Opinion on Therapeutic Patents, Volume 32, Issue 7 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 32, Issue 7 (2022)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Volume 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Patenting perspective

Article
ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective
Carlotta Granchi
Pages: 731-742
Published online: 25 Apr 2022
AbstractforATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective | Full Text | References | PDF (545.6 KB) | EPUB
  • 759 Views
  • 5 CrossRef citations
  • 0Altmetric

Review

Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and NPP2/ ATX as important drug targets: A patent review (2015-2020)
Sehrish Bano, Mariya Al-Rashida, Rima D Alharthy, Imtiaz Ali Khan & Jamshed Iqbal
Pages: 743-751
Published online: 12 Apr 2022
AbstractforNucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and NPP2/ ATX as important drug targets: A patent review (2015-2020) | Full Text | References | PDF (588.7 KB) | EPUB
  • 249 Views
  • 1 CrossRef citations
  • 0Altmetric
A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present)
Peng Li, Ying Liu & Hong-Min Liu
Pages: 753-767
Published online: 31 Mar 2022
AbstractforA patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present) | Full Text | References | PDF (12.2 MB) | EPUB
  • 528 Views
  • 2 CrossRef citations
  • 0Altmetric
P2X receptor antagonists and their potential as therapeutics: a patent review (2010–2021)
Chianna Dane, Leanne Stokes & William T Jorgensen
Pages: 769-790
Published online: 11 May 2022
AbstractforP2X receptor antagonists and their potential as therapeutics: a patent review (2010–2021) | Full Text | References | PDF (2.8 MB) | EPUB
  • 628 Views
  • 4 CrossRef citations
  • 0Altmetric
Anti-viral activity of thiazole derivatives: an updated patent review
Thoraya A. Farghaly, Amani M. R. Alsaedi, Noof A. Alenazi & Marwa F. Harras
Pages: 791-815
Published online: 27 Apr 2022
AbstractforAnti-viral activity of thiazole derivatives: an updated patent review | Full Text | References | PDF (879 KB) | EPUB
  • 152 Views
  • 6 CrossRef citations
  • 0Altmetric
Carbon-11 patents (2012–2022): synthetic methodologies and novel radiotracers for PET imaging
Sridhar Goud Nerella, Priti Singh & Sanam Tulja
Pages: 817-831
Published online: 28 Apr 2022
AbstractforCarbon-11 patents (2012–2022): synthetic methodologies and novel radiotracers for PET imaging | Full Text | References | PDF (5.8 MB) | EPUB
  • 244 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Tetrahydroisoquinolines – an updated patent review for cancer treatment (2016 – present)
Ankur Kumar Tanwar et al.
Review Article | Published online: 10 Aug 2024
A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present)
Suvankar Banerjee et al.
Review Article | Published online: 9 Aug 2024
SGLT2 inhibitors for the treatment of diabetes: a patent review (2019–23)
Rahul Baghel et al.
Review Article | Published online: 2 Aug 2024
Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez et al.
Review Article | Published online: 19 Jul 2024
View all latest articles